Elequin Capital LP Novo Cure LTD Transaction History

Elequin Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $2,014 - $4,125	50 New	50 $2,000
Q4 2022 Feb 09, 2023	BUY	$63.98 - $85.37 $3,326 - $4,439	52 New	52 $3,000
Q3 2022 Nov 10, 2022	SELL	$67.99 - $89.57 $4,147 - $5,463	-61 Reduced 44.85%	75 $6,000
Q2 2022 Aug 11, 2022	BUY	$56.6 - $89.9 $2,037 - $3,236	36 Added 36.0%	136 $9,000
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $6,015 - $8,452	100 New	100 $8,000

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.66B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

Stay updated on Elequin Capital LP with notifications on news.